TRIM37 and cancer: Several studies proposed that excessive TRIM37 activity destabilizes PCM proteins, thereby compromising mitotic fidelity, which could contribute to cancer progression (Balestra et al., 2021; Meitinger et al., 2020; Yeow et al., 2020; Zhou et al., 2024).